Neurochemical Research

, Volume 33, Issue 10, pp 2126–2133 | Cite as

Promoting Optic Nerve Regeneration in Adult Mice with Pharmaceutical Approach

Original Paper

Abstract

Our previous research has suggested that lack of Bcl-2-supported axonal growth mechanisms and the presence of glial scarring following injury are major impediments of optic nerve regeneration in postnatal mice. Mice overexpressing Bcl-2 and simultaneously carrying impairment in glial scar formation supported robust optic nerve regeneration in the postnatal stage. To develop a therapeutic strategy for optic nerve damage, the combined effects of chemicals that induce Bcl-2 expression and selectively eliminate mature astrocytes—scar forming cells—were examined in mice. Mood-stabilizer, lithium, has been shown to induce Bcl-2 expression and stimulate axonal outgrowth in retinal ganglion cells in culture and in vivo. Moreover, astrotoxin (alpha-aminoadipate), a glutamate analogue, selectively kills astrocytes while has minimal effects on surrounding neurons. In the present study, we sought to determine whether concurrent applications of lithium and astrotoxin were sufficient to induce optic nerve regeneration in mice. Induction of Bcl-2 expression was detected in the ganglion cell layer (GCL) of mice that received a lithium diet in compared with control-treated group. Moreover, efficient elimination of astrocytes and glial scarring was observed in the optic nerve of mice treated with astrotoxin. Simultaneous application of lithium and astrotoxin, but not any of the drugs alone, induced robust optic nerve regeneration in adult mice. These findings further support that a combinatorial approach of concurrent activation of Bcl-2-supported growth mechanism and suppression of glial scarring is required for successful regeneration of the severed optic nerve in adult mice. They suggest a potential therapeutic strategy for treating optic nerve and CNS damage.

Keywords

Axon regeneration Lithium Astrocyte Bcl-2 Optic nerve L-α-aminoadipate 

Notes

Acknowledgments

Grant supports: EY017641 from the National Eye Institute; Department of Defense (W81XWH-04-2-0008); Massachusetts Lion’s Eye Research Fund.

References

  1. 1.
    Yick LW, Wu W, So KF et al (2000) Chondroitinase ABC promotes axonal regeneration of Clarke’s neurons after spinal cord injury. Neuroreport 11:1063–1067PubMedCrossRefGoogle Scholar
  2. 2.
    Hunt D, Coffin RS, Anderson PN (2002) The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. J Neurocytol 31:93–120PubMedCrossRefGoogle Scholar
  3. 3.
    Davies SJ, Fitch MT, Memberg SP et al (1997) Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680–683PubMedGoogle Scholar
  4. 4.
    Davies SJ, Goucher DR, Doller C et al (1999) Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19:5810–5822PubMedGoogle Scholar
  5. 5.
    Chau CH, Shum DK, Li H et al (2004) Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J 18:194–196PubMedGoogle Scholar
  6. 6.
    Kim JE, Liu BP, Park JH et al (2004) Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44:439–451PubMedCrossRefGoogle Scholar
  7. 7.
    Chen DF, Jhaveri S, Schneider GE (1995) Intrinsic changes in developing retinal neurons result in regenerative failure of their axons. Proc Natl Acad Sci USA 92:7287–7291PubMedCrossRefGoogle Scholar
  8. 8.
    Goldberg JL, Klassen MP, Hua Y et al (2002) Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296:1860–1864PubMedCrossRefGoogle Scholar
  9. 9.
    Chen DF, Schneider GE, Martinou JC et al (1997) Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385:434–439PubMedCrossRefGoogle Scholar
  10. 10.
    Chierzi S, Strettoi E, Cenni MC et al (1999) Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice. J Neurosci 19:8367–8376PubMedGoogle Scholar
  11. 11.
    Lodovichi C, Di Cristo G, Cenni MC et al (2001) Bcl-2 overexpression per se does not promote regeneration of neonatal crushed optic fibers. Eur J Neurosci 13:833–838PubMedCrossRefGoogle Scholar
  12. 12.
    Inoue T, Hosokawa M, Morigiwa K et al (2002) Bcl-2 overexpression does not enhance in vivo axonal regeneration of retinal ganglion cells after peripheral nerve transplantation in adult mice. J Neurosci 22:4468–4477PubMedGoogle Scholar
  13. 13.
    Cho KS, Yang L, Lu B et al (2005) Re-establishing the regenerative potential of central nervous system axons in postnatal mice. J Cell Sci 118:863–872PubMedCrossRefGoogle Scholar
  14. 14.
    Huang X, Wu DY, Chen G et al (2003) Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism. Invest Ophthalmol Vis Sci 44:347–354PubMedCrossRefGoogle Scholar
  15. 15.
    Chen RW, Chuang DM (1999) Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274:6039–6042PubMedCrossRefGoogle Scholar
  16. 16.
    Chen G, Zeng WZ, Yuan PX et al (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72:879–882PubMedCrossRefGoogle Scholar
  17. 17.
    Takada M, Hattori T (1986) Fine structural changes in the rat brain after local injections of gliotoxin, alpha-aminoadipic acid. Histol Histopathol 1:271–275PubMedGoogle Scholar
  18. 18.
    Khurgel M, Koo AC, Ivy GO (1996) Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate. Glia 16:351–358PubMedCrossRefGoogle Scholar
  19. 19.
    McGraw J, Hiebert GW, Steeves JD (2001) Modulating astrogliosis after neurotrauma. J Neurosci Res 63:109–115PubMedCrossRefGoogle Scholar
  20. 20.
    Cho KS, Chan PM, So KF et al (1999) Ciliary neurotrophic factor promotes the regrowth capacity but not the survival of intraorbitally axotomized retinal ganglion cells in adult hamsters. Neuroscience 94:623–628PubMedCrossRefGoogle Scholar
  21. 21.
    Miyoshi T, Kurimoto T, Fukuda Y (2006) Attempts to restore visual function after optic nerve damage in adult mammals. Adv Exp Med Biol 557:133–147PubMedCrossRefGoogle Scholar
  22. 22.
    Benowitz L, Yin Y (2008) Rewiring the injured CNS: lessons from the optic nerve. Exp Neurol 209:389–398PubMedCrossRefGoogle Scholar
  23. 23.
    Martinou JC, Dubois-Dauphin M, Staple JK et al (1994) Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017–1030PubMedCrossRefGoogle Scholar
  24. 24.
    Calabrese JR, Kasper S, Johnson G et al (2004) International consensus group on bipolar I depression treatment guidelines. J Clin Psychiatry 65:571–579PubMedCrossRefGoogle Scholar
  25. 25.
    Asher RA, Morgenstern DA, Moon LD et al (2001) Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog Brain Res 132:611–619PubMedCrossRefGoogle Scholar
  26. 26.
    Jones LL, Yamaguchi Y, Stallcup WB et al (2002) NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:2792–2803PubMedGoogle Scholar
  27. 27.
    Moon LD, Brecknell JE, Franklin RJ et al (2000) Robust regeneration of CNS axons through a track depleted of CNS glia. Exp Neurol 161:49–66PubMedCrossRefGoogle Scholar
  28. 28.
    Pilcher HR (2003) Drug research: the ups and downs of lithium. Nature 425:118–120PubMedCrossRefGoogle Scholar
  29. 29.
    Hashimoto R, Takei N, Shimazu K et al (2002) Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 43:1173–1179PubMedCrossRefGoogle Scholar
  30. 30.
    Hashimoto R, Senatorov V, Kanai H et al (2003) Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 117:55–61PubMedCrossRefGoogle Scholar
  31. 31.
    Ren M, Senatorov VV, Chen RW et al (2003) Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci USA 100:6210–6215PubMedCrossRefGoogle Scholar
  32. 32.
    Jiao J, Huang X, Feit R et al (2005) Bcl-2 signaling Ca2+ to promote the intrinsic regenerative capacity of CNS axons. EMBO J 24:1068–1078PubMedCrossRefGoogle Scholar
  33. 33.
    Chalecka-Franaszek E, Chuang DM (1999) Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 96:8745–8750PubMedCrossRefGoogle Scholar
  34. 34.
    Zhan Q, Kontny U, Iglesias M et al (1999) Inhibitory effect of Bcl-2 on p53-mediated transactivation following genotoxic stress. Oncogene 18:297–304PubMedCrossRefGoogle Scholar
  35. 35.
    Pugazhenthi S, Nesterova A, Sable C et al (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275:10761–10766PubMedCrossRefGoogle Scholar
  36. 36.
    Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24:441–443PubMedCrossRefGoogle Scholar
  37. 37.
    Ozaki N, Chuang DM (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 69:2336–2344PubMedCrossRefGoogle Scholar
  38. 38.
    Carter DA, Bray GM, Aguayo AJ (1989) Regenerated retinal ganglion cell axons can form well-differentiated synapses in the superior colliculus of adult hamsters. J Neurosci 9:4042–4050PubMedGoogle Scholar
  39. 39.
    Hankin MH, Lund RD (1990) Induction of target-directed optic axon outgrowth: effect of retinae transplanted to anophthalmic mice. Dev Biol 138:136–146PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Schepens Eye Research InstituteHarvard Medical SchoolBostonUSA
  2. 2.Department of OphthalmologyHarvard Medical SchoolBostonUSA

Personalised recommendations